Covered recipient · General Payments record
JAMES J HAKIM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,808.64
- Reported across 128 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.59 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $65.42 | 4 |
| ABBVIE INC. | $48.11 | 3 |
| PFIZER INC. | $35.84 | 2 |
| GlaxoSmithKline, LLC. | $31.24 | 2 |
| Astellas Pharma US Inc | $21.33 | 1 |
| Abbott Laboratories | $20.97 | 1 |
| Merck Sharp & Dohme Corporation | $15.73 | 1 |
| Seqirus USA Inc | $13.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.97 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125074520 | CMS |
| ABBVIE INC. | $17.14 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103864161 | CMS |
| ABBVIE INC. | $16.85 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103864163 | CMS |
| ABBVIE INC. | $14.12 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103864165 | CMS |
| Astellas Pharma US Inc | $21.33 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139282144 | CMS |
| GlaxoSmithKline, LLC. | $16.41 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116736120 | CMS |
| GlaxoSmithKline, LLC. | $14.83 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032751 | CMS |
| Merck Sharp & Dohme LLC | $15.73 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141788906 | CMS |
| Novo Nordisk Inc | $13.54 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096767090 | CMS |
| Novo Nordisk Inc | $13.19 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617144 | CMS |
| Novo Nordisk Inc | $18.20 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096946410 | CMS |
| Novo Nordisk Inc | $20.49 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096590531 | CMS |
| PFIZER INC. | $16.87 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131162074 | CMS |
| PFIZER INC. | $18.97 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131359967 | CMS |
| Seqirus USA Inc | $13.95 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125638654 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.